跳至主要内容
临床试验/CTRI/2024/02/062511
CTRI/2024/02/062511已完成不适用

Diabetic Retinopathy Microbiome Study-India (DRMS-India)

L V Prasad Eye Institute1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2024年2月17日最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
500
试验地点
1
主要终点
Gut microbiome index for diabetic retinopathy

研究概览

简要总结

DRMS is a pan-India project evaluating gut microbiome of Indians living in India with diabetes mellitus  or diabetic retinopathy . Earlier studies have shown differences in diversity and abundance of the gut microbiome in people with or without DM, but in a lower sample size and in restricted ethnicity . DRMS-India would overcome these deficits and would also compare with healthy controls . It will create a biomarker for diabetic retinopathy

研究设计

研究类型
Observational

入排标准

年龄范围
30.00 Year(s) 至 90.00 Year(s)(—)
性别
All

入选标准

  • 1.Type 2 DM attending OPD of the institute with DM of onset at 30 years or older (WHO criteria).
  • 2.Both insulin and OHA users 3.Morbidities associated with DM, CKD (chronic kidney disease), HTN (Hypertension), CAD (coronary artery disease), CVD (Cerebral vascular disease) and dyslipidemia with or without drug usage.

排除标准

  • Chronic health disorders other than those listed in inclusion.
  • 2.Usage of oral drugs in the last 3 months for a period longer than a week 3.Usage of commercially marketed pre and probiotic dietary supplements in last 1 month 4.Any use of systemic antibiotic in the last one month.

结局指标

主要结局

Gut microbiome index for diabetic retinopathy

时间窗: 3 months

次要结局

  • Regional variation in gut microbiome in diabetic retinopathy across India(3 years)

研究者

申办方类型
Other [Non Profitable Organization]
责任方
Principal Investigator
主要研究者

DrBrijesh Takkar

L V Prasad Eye Institute

研究点 (1)

Loading locations...

相似试验